366 related articles for article (PubMed ID: 15561318)
1. Reversible myocardial dysfunction: basics and evaluation.
Gowda RM; Khan IA; Vasavada BC; Sacchi TJ
Int J Cardiol; 2004 Dec; 97(3):349-53. PubMed ID: 15561318
[TBL] [Abstract][Full Text] [Related]
2. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
Vlahović A; Popović A
Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
[TBL] [Abstract][Full Text] [Related]
3. Hibernating myocardium: a review.
Heusch G; Schulz R
J Mol Cell Cardiol; 1996 Dec; 28(12):2359-72. PubMed ID: 9004153
[TBL] [Abstract][Full Text] [Related]
4. [Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].
Heusch G
Z Kardiol; 1992 Nov; 81(11):596-609. PubMed ID: 1471397
[TBL] [Abstract][Full Text] [Related]
5. Hibernating myocardium.
Brown TA
Am J Crit Care; 2001 Mar; 10(2):84-91; quiz 92-3. PubMed ID: 11244676
[TBL] [Abstract][Full Text] [Related]
6. [Pathophysiology of the "hibernating" myocardium].
Schulz R; Heusch G
Z Kardiol; 1995; 84 Suppl 4():91-100. PubMed ID: 8585279
[TBL] [Abstract][Full Text] [Related]
7. [Reversible dysfunction of myocardial contraction].
Mates M; Veselka J
Vnitr Lek; 1998 Oct; 44(10):598-605. PubMed ID: 10422494
[TBL] [Abstract][Full Text] [Related]
8. Regional blood flow and contractile function: are they matched in normal, ischemic and reperfused myocardium?
Heusch G; Schipke JD
Basic Res Cardiol; 1993; 88 Suppl 2():103-19. PubMed ID: 8147827
[TBL] [Abstract][Full Text] [Related]
9. Characterization of hibernating and stunned myocardium.
Schulz R; Heusch G
Herz; 1994 Aug; 19(4):189-203. PubMed ID: 7959533
[TBL] [Abstract][Full Text] [Related]
10. [The hibernating myocardium].
Kirkebøen KA
Tidsskr Nor Laegeforen; 1995 Jun; 115(16):1934-8. PubMed ID: 7638844
[TBL] [Abstract][Full Text] [Related]
11. [Hibernating myocardium: no involvement of endogenous adenosine].
Schulz R; Heusch G
Z Kardiol; 1996; 85 Suppl 6():177-84. PubMed ID: 9064963
[TBL] [Abstract][Full Text] [Related]
12. Characterization of "hibernating" and "stunned" myocardium with focus on the use of calcium antagonists in "stunned" myocardium.
Ehring T; Schulz R; Heusch G
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S25-33. PubMed ID: 1282610
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation.
Ferrari R; Ceconi C; Curello S; Benigno M; La Canna G; Visioli O
J Cardiovasc Pharmacol; 1996; 28 Suppl 1():S18-26. PubMed ID: 8891867
[TBL] [Abstract][Full Text] [Related]
14. Stunned and hibernating myocardium: possibility of intervention.
Ferrari R; La Canna G; Giubbini R; Visioli O
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S5-13. PubMed ID: 1282614
[TBL] [Abstract][Full Text] [Related]
15. [Postischemic ("stunned") and chronic ischemic ("hibernating") cardiac muscle].
Takác M; Koval S; Takác V
Vnitr Lek; 1995 Apr; 41(4):252-7. PubMed ID: 7762191
[TBL] [Abstract][Full Text] [Related]
16. [Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium].
Sokolova RI; Zhdanov VS
Arkh Patol; 2002; 64(1):50-4. PubMed ID: 11889704
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial viability: review of the clinical significance.
Ramos M; DePasquale E; Coplan NL
Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
[TBL] [Abstract][Full Text] [Related]
18. ["Myocardium in hibernation"--implications for clinical medicine].
Auer J; Berent R; Eber B
Wien Med Wochenschr; 2000; 150(6):123-7. PubMed ID: 10893763
[TBL] [Abstract][Full Text] [Related]
19. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
Vlahović A; Popović A
Med Pregl; 2000; 53(1-2):39-44. PubMed ID: 10953549
[TBL] [Abstract][Full Text] [Related]
20. Concept and evaluation of hibernating myocardium.
Rahimtoola SH
Annu Rev Med; 1999; 50():75-86. PubMed ID: 10073264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
